QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis
NASDAQ:QDEL - Nasdaq - US2197981051 - Common Stock - Currency: USD
QDEL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of QDEL have multiple concerns. QDEL has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year QDEL was profitable.
In the past year QDEL had a positive cash flow from operations.
In multiple years QDEL reported negative net income over the last 5 years.
In the past 5 years QDEL always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of QDEL (-31.94%) is comparable to the rest of the industry.
The Return On Equity of QDEL (-68.76%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 0.67%, QDEL is in the better half of the industry, outperforming 67.20% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for QDEL is below the industry average of 7.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.94% | ||
| ROE | -68.76% | ||
| ROIC | 0.67% |
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
1.3 Margins
Looking at the Operating Margin, with a value of 1.65%, QDEL is in the better half of the industry, outperforming 67.20% of the companies in the same industry.
In the last couple of years the Operating Margin of QDEL has declined.
With a Gross Margin value of 46.23%, QDEL is not doing good in the industry: 61.38% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of QDEL has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 46.23% |
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), QDEL is destroying value.
Compared to 1 year ago, QDEL has more shares outstanding
The number of shares outstanding for QDEL has been increased compared to 5 years ago.
The debt/assets ratio for QDEL is higher compared to a year ago.
2.2 Solvency
QDEL has an Altman-Z score of 0.96. This is a bad value and indicates that QDEL is not financially healthy and even has some risk of bankruptcy.
QDEL has a Altman-Z score (0.96) which is comparable to the rest of the industry.
QDEL has a Debt/Equity ratio of 0.72. This is a neutral value indicating QDEL is somewhat dependend on debt financing.
QDEL has a worse Debt to Equity ratio (0.72) than 69.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.96 |
ROIC/WACC0.09
WACC7.37%
2.3 Liquidity
A Current Ratio of 1.22 indicates that QDEL should not have too much problems paying its short term obligations.
QDEL's Current ratio of 1.22 is on the low side compared to the rest of the industry. QDEL is outperformed by 83.60% of its industry peers.
A Quick Ratio of 0.69 indicates that QDEL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.69, QDEL is doing worse than 88.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.69 |
3. Growth
3.1 Past
The earnings per share for QDEL have decreased strongly by -22.38% in the last year.
Measured over the past years, QDEL shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.03% on average per year.
QDEL shows a decrease in Revenue. In the last year, the revenue decreased by -7.17%.
Measured over the past years, QDEL shows a very strong growth in Revenue. The Revenue has been growing by 39.07% on average per year.
EPS 1Y (TTM)-22.38%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%68.18%
Revenue 1Y (TTM)-7.17%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-2.56%
3.2 Future
QDEL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.34% yearly.
The Revenue is expected to grow by 2.57% on average over the next years.
EPS Next Y29.93%
EPS Next 2Y34.34%
EPS Next 3Y33.27%
EPS Next 5Y28.34%
Revenue Next Year-2.54%
Revenue Next 2Y0.76%
Revenue Next 3Y2.14%
Revenue Next 5Y2.57%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
QDEL is valuated correctly with a Price/Earnings ratio of 16.90.
Based on the Price/Earnings ratio, QDEL is valued cheaply inside the industry as 82.01% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 24.21. QDEL is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 10.88, the valuation of QDEL can be described as very reasonable.
Based on the Price/Forward Earnings ratio, QDEL is valued cheaper than 91.01% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.44, QDEL is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.9 | ||
| Fwd PE | 10.88 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, QDEL is valued cheaply inside the industry as 91.53% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 9.7 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
QDEL's earnings are expected to grow with 33.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.56
PEG (5Y)N/A
EPS Next 2Y34.34%
EPS Next 3Y33.27%
5. Dividend
5.1 Amount
No dividends for QDEL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
36.34
-0.12 (-0.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners109.74%
Inst Owner Change0.77%
Ins Owners0.49%
Ins Owner Change0.49%
Market Cap2.45B
Analysts76
Price Target54.35 (49.56%)
Short Float %5.68%
Short Ratio3.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)83.37%
Min EPS beat(2)4.59%
Max EPS beat(2)162.15%
EPS beat(4)4
Avg EPS beat(4)61.93%
Min EPS beat(4)4.59%
Max EPS beat(4)162.15%
EPS beat(8)6
Avg EPS beat(8)32.62%
EPS beat(12)9
Avg EPS beat(12)35.38%
EPS beat(16)11
Avg EPS beat(16)28.34%
Revenue beat(2)1
Avg Revenue beat(2)5.13%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)11.02%
Revenue beat(4)3
Avg Revenue beat(4)3.15%
Min Revenue beat(4)-0.75%
Max Revenue beat(4)11.02%
Revenue beat(8)6
Avg Revenue beat(8)1.91%
Revenue beat(12)9
Avg Revenue beat(12)2.77%
Revenue beat(16)11
Avg Revenue beat(16)4.19%
PT rev (1m)-0.27%
PT rev (3m)0.54%
EPS NQ rev (1m)-5.87%
EPS NQ rev (3m)-10.42%
EPS NY rev (1m)-1.06%
EPS NY rev (3m)-3.62%
Revenue NQ rev (1m)-1.1%
Revenue NQ rev (3m)-2.19%
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-2.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.9 | ||
| Fwd PE | 10.88 | ||
| P/S | 0.88 | ||
| P/FCF | N/A | ||
| P/OCF | 29.53 | ||
| P/B | 0.82 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.7 |
EPS(TTM)2.15
EY5.92%
EPS(NY)3.34
Fwd EY9.19%
FCF(TTM)-1.66
FCFYN/A
OCF(TTM)1.23
OCFY3.39%
SpS41.26
BVpS44.25
TBVpS-5.94
PEG (NY)0.56
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.94% | ||
| ROE | -68.76% | ||
| ROCE | 0.84% | ||
| ROIC | 0.67% | ||
| ROICexc | 0.68% | ||
| ROICexgc | 1.86% | ||
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 46.23% | ||
| FCFM | N/A |
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexcg growth 3Y-72.1%
ROICexcg growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score3
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.29 | ||
| Cap/Depr | 43.03% | ||
| Cap/Sales | 7.01% | ||
| Interest Coverage | 0.26 | ||
| Cash Conversion | 16.63% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.69 | ||
| Altman-Z | 0.96 |
F-Score3
WACC7.37%
ROIC/WACC0.09
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.38%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%68.18%
EPS Next Y29.93%
EPS Next 2Y34.34%
EPS Next 3Y33.27%
EPS Next 5Y28.34%
Revenue 1Y (TTM)-7.17%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-2.56%
Revenue Next Year-2.54%
Revenue Next 2Y0.76%
Revenue Next 3Y2.14%
Revenue Next 5Y2.57%
EBIT growth 1Y-81.86%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year935.81%
EBIT Next 3Y135.12%
EBIT Next 5Y92.11%
FCF growth 1Y-258.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.38%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%